MNWCX
Price
$12.54
Change
-$0.06 (-0.48%)
Updated
Dec 12 closing price
Net Assets
37.96M
MNWIX
Price
$13.35
Change
-$0.05 (-0.37%)
Updated
Dec 12 closing price
Net Assets
37.96M
Interact to see
Advertisement

MNWCX vs MNWIX

Header iconMNWCX vs MNWIX Comparison
Open Charts MNWCX vs MNWIXBanner chart's image
MFS Managed Wealth C
Price$12.54
Change-$0.06 (-0.48%)
VolumeN/A
Net Assets37.96M
MFS Managed Wealth I
Price$13.35
Change-$0.05 (-0.37%)
VolumeN/A
Net Assets37.96M
MNWCX vs MNWIX Comparison Chart in %
View a ticker or compare two or three
VS
MNWCX vs. MNWIX commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNWCX is a Hold and MNWIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MNWCX (38M) and MNWIX (38M) have equal amount of cash in the bank . MNWIX pays higher dividends than MNWCX: MNWIX (1.06) vs MNWCX (0.08). MNWCX was incepted earlier than MNWIX: MNWCX (11 years) vs MNWIX (11 years). MNWCX (2.66) is less costly to investors than MNWIX (1.66). MNWCX (11.00) and MNWIX (11.00) have comparable annual turnover. MNWIX has a lower initial minimum investment than MNWCX: MNWIX (0) vs MNWCX (1000). MNWIX annual gain was more profitable for investors over the last year : 6.28 vs. MNWCX (5.27). MNWIX return over 5 years is better than : 19.30 vs. MNWCX (14.32).
MNWCXMNWIXMNWCX / MNWIX
Total Expense Ratio2.141.14188%
Annual Report Gross Expense Ratio2.661.66160%
Fund Existence11 years11 years-
Gain YTD6.5997.54487%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets38M38M100%
Annual Yield % from dividends0.081.068%
Returns for 1 year5.276.2884%
Returns for 3 years16.8819.5886%
Returns for 5 years14.3219.3074%
Returns for 10 years26.8537.3172%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNTX1.540.05
+3.36%
Rein Therapeutics Inc
OPFI10.980.24
+2.23%
OppFi
DBX27.620.42
+1.54%
Dropbox
MRK99.011.39
+1.42%
Merck & Co
AMLX13.07-0.16
-1.21%
Amylyx Pharmaceuticals